This document is page 46 of a market research report produced by Cowen Collaborative Insights on February 25, 2019. It analyzes the pricing segments of CBD body lotions and bath bombs, listing various brands like Mary's Nutritionals and Lord Jones. While the content is purely financial market analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024862', indicating it was part of a document production for a House Oversight Committee investigation (likely related to financial records subpoenaed in the Epstein/Deutsche Bank probe), though the page itself contains no direct references to Epstein.
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Listed in the watermark as the intended recipient of the report (michael.cella@cowen.com).
|
| Name | Type | Context |
|---|---|---|
| Cowen |
Authoring financial firm (Cowen Collaborative Insights).
|
|
| House Oversight Committee |
Implied by the document stamp 'HOUSE_OVERSIGHT_024862'.
|
|
| Mary's Nutritionals |
CBD brand analyzed in charts.
|
|
| Lord Jones |
CBD brand analyzed in charts.
|
|
| Blue Ridge Hemp |
CBD brand analyzed in charts.
|
|
| bella |
CBD brand analyzed in charts.
|
|
| Vertly |
CBD brand analyzed in charts.
|
|
| Cannuka |
CBD brand analyzed in charts.
|
|
| Canna Hemp |
CBD brand analyzed in charts.
|
|
| imbue botanicals |
CBD brand analyzed in charts.
|
|
| Sopris |
CBD brand analyzed in charts.
|
|
| RX CannaCare |
CBD brand analyzed in charts.
|
|
| cbdMD |
CBD brand analyzed in charts.
|
|
| CWHemp |
CBD brand analyzed in charts.
|
|
| Kush Queen |
CBD brand analyzed in charts.
|
|
| Pure Kana |
CBD brand analyzed in charts.
|
|
| lovebud |
CBD brand analyzed in charts.
|
"Body lotions offer more value per mg of CBD, relative to facial beauty products"Source
"Bath products are not surprisingly the most reasonably priced within beauty."Source
"This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited."Source
Complete text extracted from the document (1,948 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document